Impact BioMedical Inc./$IBO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Impact BioMedical Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Ticker
$IBO
Sector
Primary listing
AMEX
Employees
2
Headquarters
Website
IBO Metrics
BasicAdvanced
$46m
-
-$0.23
-
-
Price and volume
Market cap
$46m
52-week high
$0.83
52-week low
$0.37
Average daily volume
49k
Financial strength
Current ratio
0.223
Quick ratio
0.012
Total debt to equity
7.498
Interest coverage (TTM)
-10.63%
Profitability
EBITDA (TTM)
-4.12
Gross margin (TTM)
-987.18%
Net profit margin (TTM)
-32,969.23%
Operating margin (TTM)
-14,228.21%
Effective tax rate (TTM)
16.69%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-18.68%
Return on equity (TTM)
-119.66%
Valuation
Price to revenue (TTM)
612.536
Price to book
4.04
Price to tangible book (TTM)
-8.84
Price to free cash flow (TTM)
-14.269
Free cash flow yield (TTM)
-7.01%
Free cash flow per share (TTM)
-0.03
Growth
Earnings per share change (TTM)
-89.58%
3-year revenue growth (CAGR)
-7.95%
3-year earnings per share growth (CAGR)
32.11%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.